drugset / Trial / NCT01701843

Cromoglicate in Mastocytosis

NCT01701843

Phase 2 Terminated 7 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this exploratory study is to investigate the clinical efficacy of study drug (LP0074) in the treatment of Mastocytosis. The trial will be performed as a left/right comparison study in male/female subjects with mastocytosis, in a prospective, double-blinded, randomised, single centre setting.

Timeline

Start
2012-10
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cromolyn Small molecule Topical

Indications